Belvedere Trading
LLY icon

Belvedere Trading’s Eli Lilly LLY Stock Holding History

Belvedere Trading’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9
Closed -$7.49K – 841
2024
Q4 		$6.95K Buy
+9
New +$7.45K ﹤0.01% 750
2015
Q1 		– Sell
-22,080
Closed -$1.52M – 195
2014
Q4 		$1.52M Buy
+22,080
New +$1.49M 0.01% 82

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Belvedere Trading's LLY Position: Q1 2025 in Review

Belvedere Trading sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 9 shares — an estimated $7.49K sold.

Belvedere Trading first reported a position in LLY in Q4 2014 and held it in 2 quarters. The position peaked at $1.52M in Q4 2014. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Belvedere Trading reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Belvedere Trading sold 9 Eli Lilly shares in Q1 2025, an estimated $7.49K.
  • Belvedere Trading first reported a position in Eli Lilly in Q4 2014 and held it in 2 quarters.
  • Belvedere Trading's Eli Lilly position peaked at $1.52M in Q4 2014.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Belvedere Trading's 13F filing for Q1 2025, filed 9 May 2025.